Fintel reports that on February 28, 2025, Piper Sandler downgraded their outlook for Teleflex (NYSE:TFX) from Overweight to ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly ...

Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Teleflex separately reported today fourth quarter and full-year 2024 financial results and announced its entry into a ...

Shares of Teleflex Inc. slipped 4.57% to $132.75 Friday, on what proved to be an all-around great trading session for the ...

Teleflex Incorporated announced a plan to separate the company’s urology, acute care, and original equipment manufacture ...